documents: FDA-2006-N-0515-0089

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-N-0515-0089 FDA FDA-2006-N-0515 Reference 2 O'Reilly, Pharma scales back drug samples to physician offices re Ref2 Final Regulatory Impact Analysis for Docket No. FDA-2006-N-0515 (formerly Docket No. 2006N-0467) Supporting & Related Material Background Material 2014-12-04T05:00:00Z 2014 12     2014-12-30T18:19:54Z   0 0 090000648199a461

Links from other tables